Moderna
MRNA
#797
Rank
โ‚ฌ22.78 B
Marketcap
59,28ย โ‚ฌ
Share price
-3.43%
Change (1 day)
-38.95%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Revenue for Moderna (MRNA)

Revenue in 2024 (TTM): โ‚ฌ4.59 B

According to Moderna 's latest financial reports the company's current revenue (TTM) is โ‚ฌ4.50 B. In 2023 the company made a revenue of โ‚ฌ6.10 B a decrease over the revenue in the year 2022 that were of โ‚ฌ17.59 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Moderna from 2018 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ4.59 B-24.82%
2023 โ‚ฌ6.10 B-65.28%
2022 โ‚ฌ17.59 B12.87%
2021 โ‚ฌ15.58 B6845.44%
2020 โ‚ฌ0.22 B424.66%
2019 โ‚ฌ42.78 M-60.08%
2018 โ‚ฌ0.10 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.38 B 1,152.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.07 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.11 B-53.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ44.09 B 879.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ17.73 M-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ78.12 B 1,635.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.17 B-96.13%๐Ÿ‡บ๐Ÿ‡ธ USA